Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis

This is the largest RWD study of systemic mHSPC treatment. Despite evidence, ADT monotherapy remains the most used first-line therapy. Increased use ADT + ARPI is associated with better persistence and improved outcomes in the real-world setting, supporting its broader adoption in clinical practice.

Authors

Institutions

Publication Details

Journal
European Urology Oncology
Published
2025-10-01
DOI
https://doi.org/10.1016/j.euo.2025.08.007
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis

Paweł Rajwa, Robert Snijder, Mauro Gacci, Susan Evans‐Axelsson et al.
1 citations
European Urology Oncology
Prostate Cancer Treatment and Research
1.52
article

Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis

Paweł Rajwa, Robert Snijder, Mauro Gacci, Susan Evans‐Axelsson, Anders Bjartell, Axel S. Merseburger, James T. Brash, Katharina Beyer, Ayman Hijazy, Qi Feng, Alex Qinyang Liu, Monique J. Roobol, Asieh Golozar, Riccardo Campi, James N’Dow, Eleanor Davies, Philip Cornford, Bertrand De Meulder, Jeremy Yuen‐Chun Teoh, Rossella Nicoletti, Jesús Moreno Sierra, Juan Gomez Rivas, Thomas A. Abbott, Peter-Paul M. Willemse, Teemu Murtola, Carl Steinbesser, Artem Harbachou
article en
1 citations

Abstract

This is the largest RWD study of systemic mHSPC treatment. Despite evidence, ADT monotherapy remains the most used first-line therapy. Increased use ADT + ARPI is associated with better persistence and improved outcomes in the real-world setting, supporting its broader adoption in clinical practice.

European Urology OncologyVol. 8(5)
Northeastern University (US), Project Management Institute (US), Chinese University of Hong Kong (HK), Lund University (SE), University of Aberdeen (GB), European Association of Urology (NL), Erasmus MC (NL), IQVIA (United Kingdom) (GB), Hospital Clínico San Carlos (ES), University Medical Center Utrecht (NL), Comprehensive Cancer Center Vienna (AT), University Hospital Schleswig-Holstein (DE), Azienda Ospedaliero-Universitaria Careggi (IT), Tampere University Hospital (FI), Tampere University (FI), Erasmus MC Cancer Institute (NL), Electronic Product Services (Czechia) (CZ), University of Florence (IT), University College London (GB), University of Lübeck (DE)
Openalex Percentile: Top 14%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.